North America holds a dominant share of the global plasma fractionation market due to its strong healthcare infrastructure, extensive plasma collection network, and increasing demand for plasma-derived medicinal products. The region benefits from growing awareness regarding rare and chronic diseases, expanding patient access to advanced biologic therapies, and significant investments in...